Skip to main content
All lobbying filings

Biomerieux

Biomerieux filed a Q4 report for Biomerieux on January 20, 2026.

Lobbying for Biomerieux · Medical diagnostics

As filed: BIOMERIEUX for BIOMERIEUX.

All filings by Biomerieux · Everything Biomerieux has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Expenses
$160,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Utah

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4

Discussions regarding Veterans Affairs Appropriations Discussions regarding Indian Health Services Appropriations

Discussions regarding tariff proposals

Issues regarding womens health Equitable Community Access to Pharmacists Services Act

Discussions regarding PASTEUR Act, the RESULTS Act, CLIA Modernization, and antimicrobial resistance.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem